Your browser doesn't support javascript.
loading
Bioterápico 17DH T. cruzi em uso prolongado melhora clinicamente camundongos infectados pelo Trypanosoma cruzi / Biotherapic T. cruzi 17DH when continuously used clinically improves mice infected with Trypanosoma cruzi.
Aleixo, Denise Lessa ; Ferreira, Érika Cristina ; Braga, Caroline Felício; Lopes, Carina Ribeiro ; Falkowski, Gislaine Janaina Sanchez ; Sandri, Patrícia Flora ; Araújo, Silvana Marques de.
Affiliation
  • Aleixo, Denise Lessa ; tate University of Maringá, Maringá. PR. Brazil
  • Ferreira, Érika Cristina ; tate University of Maringá, Maringá. PR. Brazil
  • Braga, Caroline Felício; tate University of Maringá, Maringá. PR. Brazil
  • Lopes, Carina Ribeiro ; tate University of Maringá, Maringá. PR. Brazil
  • Falkowski, Gislaine Janaina Sanchez ; tate University of Maringá, Maringá. PR. Brazil
  • Sandri, Patrícia Flora ; tate University of Maringá, Maringá. PR. Brazil
  • Araújo, Silvana Marques de; tate University of Maringá, Maringá. PR. Brazil
Int. j. high dilution res ; 10(36): 134-137, september 30, 2011.
Article in English | LILACS-Express | HomeoIndex Homeopathy | ID: hom-10720
Responsible library: BR1.1
ABSTRACT

Introduction:

In Trypanosoma cruzi infection, the pathogenesis is the result of a rupture in the host - parasite relationship [1]. This rupture is related to the imbalance of the vital force of the host, expressed through signs and symptoms, defined by Hahnemann (1995)[2] as being the source of the disease. There is no research in the literature about the clinical evolution of mice experimentally infected with T. cruzi and treated in different ways using biotherapic. Therefore, this is an area to be studied in the future.

Conclusion:

The use of biotherapic T. cruzi 17DH for a long period causes clinical improvement of the infected mice with Trypanosoma cruzi. The clinical use of these results in human beings should consider the allometric medicine dosage which takes into account the metabolic rate of each organism(AU)
RESUMO

Introdução:

Na infecção pelo Trypanosoma cruzi, a patogenia é resultado do rompimento do equilíbrio da relação parasito - hospedeiro (Tafuri, 1987), que está relacionada com o desequilíbrio da força vital do hospedeiro, expressando-se através de sinais e sintomas, definido por Hahnemann (2007), como sendo a origem da doença. Não existe na literatura trabalhos que abordem a evolução clínica de camundongos experimentalmente infectados pelo T. cruzi e tratados com diferentes esquemas de tratamento utilizando bioterápico. Sendo assim, é necessária a realização de estudos com este objetivo.

Conclusão:

O uso prolongado do bioterápico 17DH T. cruzi melhora clinicamente camundongos infectados pelo T. cruzi. A utilização clínica destes resultados em humanos, deve considerar o sistema alométrico de dosagem de medicamentos que leva em conta a taxa metabólica de cada organismo.(AU)
Subject(s)

Full text: Available Collection: Tematic databases Health context: Neglected Diseases Health problem: Chagas Disease / Neglected Diseases Database: HomeoIndex Homeopathy Main subject: Trypanosoma cruzi / Biotherapics Language: English Journal: Int. j. high dilution res Year: 2011 Document type: Article Institution/Affiliation country: tate University of Maringá, Maringá/Brazil
Full text: Available Collection: Tematic databases Health context: Neglected Diseases Health problem: Chagas Disease / Neglected Diseases Database: HomeoIndex Homeopathy Main subject: Trypanosoma cruzi / Biotherapics Language: English Journal: Int. j. high dilution res Year: 2011 Document type: Article Institution/Affiliation country: tate University of Maringá, Maringá/Brazil
...